P. G. De Groot
About
In The Last Decade
P. G. De Groot
19 papers receiving 622 citations
Peers
Comparison fields: 5 of 76
- Hematology 400
- Surgery 148
- Pulmonary and Respiratory Medicine 142
- Rheumatology 128
- Cardiology and Cardiovascular Medicine 116
Countries citing papers authored by P. G. De Groot
This map shows the geographic impact of P. G. De Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. G. De Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. G. De Groot more than expected).
Fields of papers citing papers by P. G. De Groot
This network shows the impact of papers produced by P. G. De Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. G. De Groot. The network helps show where P. G. De Groot may publish in the future.
Co-authorship network of co-authors of P. G. De Groot
This figure shows the co-authorship network connecting the top 25 collaborators of P. G. De Groot. A scholar is included among the top collaborators of P. G. De Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. G. De Groot. P. G. De Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 56 | |
| 3 | 39 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | Lupus anticoagulant in cardiovascular diseases: the role of beta2-glycoprotein I. | 9 |
| 8 | 8 | |
| 9 | 13 | |
| 10 | Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis. | 40 |
| 11 | Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. | 57 |
| 12 | The presence of anti-beta 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. | 4 |
| 13 | 29 | |
| 14 | The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors. | 12 |
| 15 | 28 | |
| 16 | 4 | |
| 17 | 21 | |
| 18 | Internalization of antithrombin III by cultured human endothelial cells and its subcellular localization. | 4 |
| 19 | A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. | 327 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.